Edition:
United States

Nate Raymond

Maryland asks U.S. Supreme Court to revive drug price-gouging law

Oct 19 2018

Maryland on Friday asked the U.S. Supreme Court to take a case about whether it can enforce a 2017 state law that allows its attorney general to sue generic drugmakers who sharply raise prices on medications without running afoul of the U.S. Constitution.

Allergan seeks Ropes & Gray records in lawsuit over compounded drugs

Oct 19 2018

Allergan PLC is seeking to force two related companies that sell compounded medications that compete with its Aczone acne treatment to disclose their communications with law firm Ropes & Gray, which wrote a memo supporting their business model's legality.

Whistleblower can't intervene in 'pill mill' doctors' forfeiture proceedings

Oct 18 2018

A former employee of two Alabama doctors convicted of operating a pill mill may not intervene in their criminal case to claim a cut of funds they forfeited as a reward for pursuing a related whistleblower case, a federal appeals court has ruled.

Boehringer hit with $1.25 mln verdict in case over Pradaxa risks

Oct 18 2018

A federal jury has awarded the family of a deceased West Virginia woman $1.25 million after finding that Boehringer Ingelheim misrepresented the risks of its blood thinner Pradaxa, causing her to suffer gastrointestinal bleeding.

Compounding pharmacy fraud case unsealed despite U.S. objections

Oct 17 2018

A federal judge in Philadelphia has taken the unusual step of ordering the unsealing of a whistleblower lawsuit accusing a compounding pharmacy of defrauding government healthcare programs despite requests by the U.S. Justice Department to keep the case sealed.

Generic drugmakers lose bid to dismiss price-fixing lawsuits

Oct 17 2018

A federal judge has rejected motions by 20 drug companies including Mylan NV and Teva Pharmaceutical Industries Ltd to dismiss lawsuits accusing them of conspiring to raise the prices for six generic drugs including the common antibiotic doxycycline.

Judge increases fee holdback for testosterone replacement cases

Oct 16 2018

A federal judge has nearly doubled how much must be held back from any settlements with testosterone replacement drug manufacturers to potentially compensate plaintiffs lawyers for working on matters related to the mass tort litigation.

Allergan defeats Asacol antitrust class action certification

Oct 16 2018

A federal appeals court has overturned the certification of a class of purchasers of Asacol, an ulcerative colitis drug, who accused drug manufacturer Warner Chilcott, now owned by Allergan PLC, of suppressing generic competition for the medication.

Minnesota accuses insulin makers of deceptive drug pricing

Oct 16 2018

Minnesota's attorney general on Tuesday filed a lawsuit accusing drug manufacturers Sanofi SA, Novo Nordisk and Eli Lilly and Co of deceptively raising prices for insulin.

Ex-State Street exec gets prison in U.S. for defrauding clients

Oct 16 2018

BOSTON A former State Street Corp executive was sentenced on Tuesday to 18 months in prison after being convicted of taking part in a scheme to overcharge customers of the bank by applying secret commissions on billions of dollars' worth of trades.

World News